Search Results

Filter
  • 1-10 of  1,721 results for ""Nanoparticles""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Ligand concentration determines antiviral efficacy of silica multivalent nanoparticles.

  • Authors : Wang H; Institute of Materials, École Polytechnique Fédérale de Lausanne (EPFL), Station 12, CH-1015 Lausanne, Switzerland.; Xu X

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry; Humans

  • Source: Journal of colloid and interface science [J Colloid Interface Sci] 2024 Mar; Vol. 657, pp. 327-333. Date of Electronic Publication: 2023 Nov 23.Publisher: Academic Press Country of Publication: United States NLM ID: 0043125 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluating Cationic Nanoparticles as Carriers of Antiviral Nucleic Acids.

  • Authors : Jadaa N; Wilfrid Laurier University, Waterloo, ON, Canada.; Aldor N

Subjects: Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Nucleic Acids*/Nucleic Acids*/Nucleic Acids*/chemistry

  • Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2813, pp. 309-320.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029

Record details

×
Academic Journal

Long-Acting Protective Ocular Surface by Instilling Adhesive Dual-Antiviral Nanoparticles.

  • Authors : Wang X; Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; Chen L

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Eye*/Eye*/Eye*/drug effects ; Eye*/Eye*/Eye*/virology

  • Source: Advanced healthcare materials [Adv Healthc Mater] 2022 Jul; Vol. 11 (14), pp. e2200283. Date of Electronic Publication: 2022 May 27.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659

Record details

×
Academic Journal

Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment.

  • Authors : Hanafy NAN; Nanomedicine group, Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, 33516 Kafrelsheikh, Egypt. Electronic address: .; El-Kemary MA

Subjects: COVID-19 Drug Treatment*; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacology ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2022 Feb 15; Vol. 198, pp. 101-110. Date of Electronic Publication: 2021 Dec 28.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Nanoparticles as a novel and promising antiviral platform in veterinary medicine.

  • Authors : Fawzy M; Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, 41522, Egypt. .; Khairy GM

Subjects: Veterinary Medicine*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Nanoparticles/Nanoparticles/Nanoparticles/*therapeutic use

  • Source: Archives of virology [Arch Virol] 2021 Oct; Vol. 166 (10), pp. 2673-2682. Date of Electronic Publication: 2021 Jul 23.Publisher: Springer-Verlag Country of Publication: Austria NLM ID: 7506870 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.

Subjects: COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Aptamers, Nucleotide/Aptamers, Nucleotide/Aptamers, Nucleotide/*chemistry

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2022 Feb; Vol. 99 (2), pp. 233-246. Date of Electronic Publication: 2021 Nov 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Zn-based physiometacomposite nanoparticles: distribution, tolerance, imaging, and antiviral and anticancer activity.

  • Authors : DeLong RK; Department of Anatomy & Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.; Nanotechnology Innovation Center, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Nanoparticles*; Animals

  • Source: Nanomedicine (London, England) [Nanomedicine (Lond)] 2021 Sep; Vol. 16 (21), pp. 1857-1872. Date of Electronic Publication: 2021 Jul 20.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101278111 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antiviral potential of plant polysaccharide nanoparticles actuating non-specific immunity.

  • Authors : Stovbun SV; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia.; Kalinina TS

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/chemistry ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacokinetics ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2021 Jul 01; Vol. 182, pp. 743-749. Date of Electronic Publication: 2021 Apr 05.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment.

  • Authors : Zhao Z; Center for Infection and Immunity, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.; Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Glycyrrhizic Acid/Glycyrrhizic Acid/Glycyrrhizic Acid/*therapeutic use

  • Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 May 12; Vol. 13 (18), pp. 20995-21006. Date of Electronic Publication: 2021 Apr 30.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy.

  • Authors : Kelleni MT; Pharmacology Department, College of Medicine, Minia University, Egypt. Electronic address: .

Subjects: Drug Delivery Systems* ; Nanoparticles* ; COVID-19 Drug Treatment*

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Jul; Vol. 139, pp. 111626. Date of Electronic Publication: 2021 Apr 21.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  1,721 results for ""Nanoparticles""